Skip to main content
An official website of the United States government

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Balaj, Leonora

Massachusetts General Hospital
United States

Standardized Molecular Analyses of Glioma EVs 5R01CA237500-05 Matthew Young, Ph.D.
Balskus, Emily Patricia

Harvard University
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297577-01S1 Asad Umar, D.V.M., Ph.D.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 4R01CA259019-04 Guillermo Marquez, Ph.D.
Banerjee, Imon

Mayo Clinic Arizona
United States

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer 5R01CA289249-02 Nicholas Hodges, Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 5R37CA248563-05 Asad Umar, D.V.M., Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 5R37CA248563-05 Asad Umar, D.V.M., Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 5R37CA248563-05 Asad Umar, D.V.M., Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Barber, Glen N.

Ohio State University
United States

Development of A HTLV-1 Vaccine 7R01CA252049-05 Marjorie Perloff, M.D.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation 5R01CA238423-05 Goli Samimi, Ph.D., M.P.H.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

The MW Cancer Prevention Clinical Trials Network 5UG1CA242635-05 Donald Johnsey
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 5R01CA279401-02 Rachel Altshuler, Ph.D.